cyclopentane has been researched along with Adenoma, Prostatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiola, OJ; Adaramoye, OA; Akanni, OO; Akinloye, O; Olapade-Olaopa, EO; Owumi, SE | 1 |
| Abiola, OJ; Adaramoye, OA; Akanni, OO | 1 |
| Bernstein-Hahn, L; Sember, M | 1 |
3 other study(ies) available for cyclopentane and Adenoma, Prostatic
| Article | Year |
|---|---|
Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Topics: Acetates; Animals; Apoptosis; Biomarkers; Cyclopentanes; Finasteride; Inflammation; Lipids; Male; Metabolic Detoxication, Phase I; Nitric Oxide; Organ Size; Oxylipins; Prostate; Prostatic Hyperplasia; Rats, Wistar; Testosterone; Weight Gain | 2017 |
Methyl Jasmonate Ameliorates Testosterone Propionate-induced Prostatic Hyperplasia in Castrated Wistar Rats.
Topics: Acetates; Animals; Cyclopentanes; Humans; Male; Oxylipins; Plant Extracts; Prostatic Hyperplasia; Rats; Rats, Wistar; Testosterone; Testosterone Propionate | 2017 |
[Hormone treatment of benign prostatic hypertrophy].
Topics: Aged; Cyclopentanes; Estradiol; Humans; Male; Middle Aged; Propionates; Prostatic Hyperplasia; Testosterone | 1969 |